Biocompatibility of Intracanal Medications Based on Calcium Hydroxide
Figure 3
Light micrographs of sections showing portions of capsules adjacent to the opening of the tubes (I) filled with Hydropast after 7 (a) and 30 days (b) of implantation in the subcutaneous. In (a), numerous inflammatory cells (ICs) and multinucleated giant cells (GCs) are present by thorough capsule. BVs, blood vessels 120. (b) The capsule contains predominantly inflammatory cells (arrows); scarce collagen fibers (FC) distributed irregularly are observed in the capsule. BVs, blood vessels 120.
